Fibroma-Like PEComa as an Early Indicator of Tuberous Sclerosis Complex: Confirmed With Strong GPNMB Expression and TSC2 Germline Mutation
International Journal of Surgical Pathology · 2026
DOI: 10.1177/10668969251407227 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Surgical Pathology, 2026. Verfasst von Xiaona Yin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ningbo Clinical Pathology Diagnosis Center, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Tuberous Sclerosis Complex 2 Protein, Perivascular Epithelioid Cell Neoplasms, Tuberous Sclerosis, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Ningbo Top Medical and Health Research Program.
Abstract (Originalsprache)
Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms defined by co-expression of melanocytic and smooth muscle markers, with fibroma-like PEComa representing a novel and recently described subtype strongly associated with tuberous sclerosis complex (TSC). This article reports the eighth documented example of fibroma-like PEComa, occurring in the subcutaneous wrist tissue of a 6-year-old girl with no prior clinical or family history of TSC. Histopathological examination revealed a hypocellular to moderately cellular proliferation of bland oval, spindle to stellate cells within dense collagenous stroma, accompanied by focal myxoid change and scattered mature adipose tissue. Immunohistochemically, the tumor exhibited diffuse strong glycoprotein nonmetastatic melanoma protein B (GPNMB) expression and focal positivity for HMB45, melan-A, and desmin. DNA-based target next-generation sequencing identified a germline TSC2 nonsense mutation (c.268C > T, p.Q90*) with a variant allele frequency of 83%, confirmed via peripheral blood testing, leading to a definitive diagnosis of TSC. A review of all 8 reported tumors confirms that fibroma-like PEComa occurs predominantly in children and young adults, shows a female predilection (5:3), and favors extremity locations. These tumors typically demonstrate benign behavior with no recurrences or metastases reported. Our report highlights that fibroma-like PEComa can serve as an early indicator of occult TSC and underscores the diagnostic utility of GPNMB immunohistochemistry as a surrogate marker of TSC1/2/MTOR pathway activation. Comprehensive clinical and genetic evaluation for TSC is recommended upon diagnosis of this rare tumor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ningbo Clinical Pathology Diagnosis Center, Ningbo, Zhejiang, China.
- Department of Pathology, Chain Medical Labs, Hangzhou, Zhejiang, China.
ORCID-Profile: Ming Zhao
Förderung
- Ningbo Top Medical and Health Research Program
Zitieren
APA
Yin, X., Ye, L., & Zhao, M. (2026). Fibroma-Like PEComa as an Early Indicator of Tuberous Sclerosis Complex: Confirmed With Strong GPNMB Expression and TSC2 Germline Mutation. International Journal of Surgical Pathology. https://doi.org/10.1177/10668969251407227
Vancouver
Yin X, Ye L, Zhao M. Fibroma-Like PEComa as an Early Indicator of Tuberous Sclerosis Complex: Confirmed With Strong GPNMB Expression and TSC2 Germline Mutation. International Journal of Surgical Pathology. 2026. doi:10.1177/10668969251407227
BibTeX
@article{Yin2026,
author = {Yin, Xiaona and Ye, Lin and Zhao, Ming},
title = {Fibroma-Like PEComa as an Early Indicator of Tuberous Sclerosis Complex: Confirmed With Strong GPNMB Expression and TSC2 Germline Mutation},
journal = {International Journal of Surgical Pathology},
year = {2026},
doi = {10.1177/10668969251407227}
}
EUVIMED